Cervical Cancer Center

The US Food and Drug Administration (FDA) has approved the United States' first biosimilar drug to treat cancer.

Many parents are choosing for their teens to receive the human papillomavirus (HPV) vaccine.

A simple vaccine could prevent cancer for hundreds of thousands of women around the world each year, according to new research.

Despite human papillomavirus (HPV) vaccination programs becoming available to the public in 2009, vaccination rates among men remained relatively low, a new study found.

Most people would agree that cancer screening is a good thing. After all, you're either preventing cancer or catching it early. Unfortunately, the majority of cancer screening guidelines may be lacking in important patient information.

In the US, routine HPV vaccination is recommended for all girls before age 13. So why are so many still not getting vaccinated?

Many parents know the human papillomavirus (HPV) vaccine can protect against cervical cancer. But new evidence suggests that some US teens are still not getting vaccinated.

Doctors don't usually encourage patients to deviate from their vaccination schedules, but new evidence suggests that less may actually be more — at least when it comes to the HPV vaccine.

Catching cancer early can save lives, but screening too often — without good reason — may be costly and harmful.

Public health campaigns and billboards promoting cancer screening abound, but are these efforts working?

New guidelines may change many women's preventive health care routines — particularly when it comes to cervical cancer screening.

Getting abnormal Pap smear results can be scary — a fear that is sometimes compounded by a fear that follow-up procedures may reduce fertility. New evidence suggests, however, that many women who undergo these procedures can expect joyful surprises later in life.

Some parents have raised concerns that vaccinating young girls against HPV, a sexually transmitted illness, might lead to more unsafe sexual activity in these girls. New evidence, however, suggests that's not the case — and the vaccine could prevent serious health problems.

Pap smears may be passé for some women. A new cervical cancer test may be coming into vogue.

It's a clean vaccine — the HPV shot doesn't appear to raise patients' risk of nervous system diseases.

The US Food and Drug Administration (FDA) today approved a vaccine to prevent several types of cancer associated with human papillomavirus (HPV).

Pap tests have saved many lives by detecting cervical cancer early. But, according to new research from the Centers for Disease Control and Prevention (CDC), millions of women may not be getting screened for this disease.

Regular cancer screenings are widely regarded as an important part of preventive medicine, particularly for people in midlife. But those same screenings might cause more harm than good in older patients facing a limited life expectancy.

Many people want to slim down to cut their risks for heart disease and diabetes, but a new study suggests that being overweight may also affect cancer risk.

One of the few vaccines that can actually protect against cancer is the human papillomavirus (HPV) vaccine, which prevents four strains of HPV. But some parents have expressed concerns about the safety of the HPV vaccine.